Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

FLAGYL I.V.

METRONIDAZOLE HYDROCHLORIDE

Standard Dose
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview FLAGYL I.V. is listed in Drugs@FDA under application 018353 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METRONIDAZOLE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 2015-07-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLAGYL I.V. is listed in Drugs@FDA under application 018353 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METRONIDAZOLE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 2015-07-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FLAGYL I.V. (METRONIDAZOLE HYDROCHLORIDE) | Drug Monograph | MedicHelpline